These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3022272

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Angiotensin-converting enzyme inhibition: side effects and risks].
    Schilling H, Scheler F.
    Z Kardiol; 1988; 77 Suppl 3():47-54. PubMed ID: 2850687
    [Abstract] [Full Text] [Related]

  • 5. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD, Ikem RT, Adigun AQ, Akintomide AO, Balogun MO, Ajayi AA.
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ.
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [Abstract] [Full Text] [Related]

  • 9. [Side effects of vasodilator therapy in heart failure: risk of hypotension with ACE inhibitors].
    Kromer EP, Elsner D, Riegger GA.
    Z Kardiol; 1991 Jul; 80 Suppl 2():11-5. PubMed ID: 2024538
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ.
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM, Kramer BL, Topic N.
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D, Frey FJ, Ferrari P.
    Praxis (Bern 1994); 2000 Dec 07; 89(49):2073-6. PubMed ID: 11190849
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ, Laragh JH, Atlas SA, Case DB.
    J Hypertens Suppl; 1983 Oct 07; 1(1):77-84. PubMed ID: 6085835
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].
    Risler T, Braun U, Klärner HG, Müller-Schauenburg W, Heitkamp HC, Brilla GG, Krämer BK, Seipel L.
    Z Kardiol; 1991 Oct 07; 80 Suppl 2():40-3. PubMed ID: 1850942
    [Abstract] [Full Text] [Related]

  • 20. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L, Apostolou T, Bonoris P, Foussas S, Lefkos N, Zombolos S.
    Curr Med Res Opin; 2001 Oct 07; 17(4):290-7. PubMed ID: 11922403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.